In a homozygous affected patient with maple syrup urine disease, pharmacologic doses of thiamine lowered urinary excretion of branched chain a-ketoacids and stimulated branched chain a-ketoacid dehydrogenase (BCKAD) in his peripheral blood leukocvtes. Suvvlementation of his branched chain aminoacid restricted diei h t h 100 mglday of thiamine eliminated recurrent episodes of ketoacidosis.~hese clinical responses were studied in vitro using mitochondria1 inner membranes prepared from his cultured skin fibroblasts and those from another thiamine-responsive patient from Canada. BCKAD in both mutant cell lines had similarities to normal enzyme including: identical apparent K,,, value for thiamine pyrophosphate; similar heat inactivation profdes which were slowed by the presence of thiamine pyrophosphate; and stimulation above basal activity by thiamine pyrophosphate. Differences in the enzymes included: decreased apparent V , , , for thiamine pyrophosphate; increased lability at 37"; and failure to respond to added NAD+, CoASH, and MgZ+.
Summary
In a homozygous affected patient with maple syrup urine disease, pharmacologic doses of thiamine lowered urinary excretion of branched chain a-ketoacids and stimulated branched chain a-ketoacid dehydrogenase (BCKAD) in his peripheral blood leukocvtes. Suvvlementation of his branched chain aminoacid restricted diei h t h 100 mglday of thiamine eliminated recurrent episodes of ketoacidosis.~hese clinical responses were studied in vitro using mitochondria1 inner membranes prepared from his cultured skin fibroblasts and those from another thiamine-responsive patient from Canada. BCKAD in both mutant cell lines had similarities to normal enzyme including: identical apparent K,,, value for thiamine pyrophosphate; similar heat inactivation profdes which were slowed by the presence of thiamine pyrophosphate; and stimulation above basal activity by thiamine pyrophosphate. Differences in the enzymes included: decreased apparent V , , , for thiamine pyrophosphate; increased lability at 37"; and failure to respond to added NAD+, CoASH, and MgZ+.
We propose that "excess" thiamine led to increased available thiamine pyrophosphate which stabilized the branched chain aketoacid dehydrogenase, decreased biologic turnover, increased enzyme specific activity and produced in vivo tolerance to branched chain aminoacids in these patients with maple syrup urine disease.
Speculation
By studying the partially purified normal and mutant branched chain a-ketoacid dehydrogenases from cultured human fibroblasts, direct in vitro effects of thiamine pyrophosphate can be measured and related to in vivo clinical responses. This should improve and extend the treatment and management of patients with maple syrup urine disease and provide a method for study of other mutant human enzymes located in the mitochondrial membrane.
. .
INTRODUCTION
Thiamine responsive maple syrup urine disease (ffiUD) was f i r s t described i n 1971. Oral loading with vitamin B decreased previously elevated plasma branched chain amino acid concentratiAns i n a presumably homozygous affected Canadian female c h i l d (22) . I n a preliminary study we reported a similar e f f e c t from high doses of o r a l thiamine on two homozygous affected brothers (6) . MSUD r e s u l t s from a epecific decrease i n t h e a c t i v i t y of branched chain a-ketoacid dehydrogenase (BCKAD) which oxidatively decarboxylates a-ketoisocaproate (KIc), a-keto-0-methylvalerate (KMV) and a-ketoisovalerate (KIV), t h e transaminated products of leucine, isoleucine and valine respectively (9.25).
BCKAD is thought t o be a multienzyme complex composed of a decarboxyl a s e , a transacylase and lipoamide oxidoreductase i n which thiamine pyrophosphate (TPP) i s a cofactor f o r t h e f i r s t component (5.24) .
I n t r a c e l l u l a r concentration of t h i s cofactor can most l i k e l y be increased by o r a l loading since thiamine kinase i s a c t i v e i n the i n t e s t i n e and most other t i s s u e s of man (15, 17.18.23) .
Vitamin responsive inborn e r r o r s of metaboliam have been recognized f o r a number of years and our understanding of t h e mechanism by which these responses a r e realized continues t o advance (1.12.13,16,19.20.22) .
Classically. holoenzyme function was augmented by mass action through increased coenzyme production and binding t o apoenzyme. I n a more recently postulated mechanism, t h e presence of "excess" coenzyme decreased t h e degradation o f holoenzyme (12.13) .
This mechanism was invoked a s t h e means by which 'ITP improved BCKAE a c t i v i t y (4, 6) .
Supraphysiologic ingestion of thiamine increased BCKAD a c t iv i t y i n normal adult l i v e r by 2 fold, but required t h r e e weeks, t h e approximate biological h a l f l i f e of mitochondrial turnover (4) . Because BCKAD i s expressed incultured human skin fibroblasts, and a decreased a c t i v i t y i s observed i n c e l l s from MSLRI p a t i e n t s , t h i a t i s s u e was used t o study i n v i t r o t h e e f f e c t of TPP (2-6.9 ).
Here we report t h e e f f e c t of o r a l loading with thiamine on urine concentrations of t h e branched chain a-ketoacids and on enzyme funct i o n i n i s o l a t e d white blood c e l l s from a single homozygous affected patient.
W e a l s o report studies on t h e e f f e c t of TPP on BCKAD a c t i v i t y i n i s o l a t e d mitochondrial inner membranes from f i b r o b l a s t s cultured from t h i s thiamine responsive p a t i e n t , t h e Canadian p a t i e n t and normal controls.
METHOLX ARD MATERIALS
Following detailed description o f t h e research p r o j e c t and obtaining informed parental consent, a homozygous affected EUD p a t i e n t was admitted t o t h e C l i n i c a l Research F a c i l i t y a t Emory University where continuous supervision of h i s d i e t was possible. This patient's synthetic d i e t was r e s t r i c t e d i n branched chain amino acids and supplemented with Recommended Dietary Allowances of a l l vitamins including 5 mg/day of thiamine. After 1 week of s t a b i l i z a t i o n , t h e study was begun.. After no added thiamine, t h e d i e t was then supplemented with 50. 100 and 150 mg of thiamine-HC1. respect i v e l y f o r each of t h r e e succeeding weeks. A 24 hour urine was collected on day 1.3. and 7. and 1 0 ml of heparinized blood was collected a f t e r day 3 of each of four weekly periods. White blood c e l l a were prepared from t h e unclotted blpod using t h e polyvinyl pyrollidone method (20). These c e l l s were used f r e s h f o r assay of t h e BCKAD a c t i v i t y .
Punch skin biopsy was used t o obtain a primary c u l t u r e of f i b r o b l a s t s from t h i s p a t i e n t (Mutant A). Fibroblasts cultured from t h e previously reported thiamine responsive p a t i e n t were purchased fromTne.Repository for ' Human Mutant Cell S t r a i n s i n Canada (Mutant B). Cells were g r m i n 690 cm2 Bellco r o l l e r b o t t l e s using Mbecco-Vogt medium supplemented v i t h 15% f e t a l c a l f serum. Cells were harvested when confluent. usually 7 days, by treatment with 0.25% t r y p s i n f o r 30 minutes a t 37O. Three t o four r o l l e r b o t t l e s yielded between 0.75 and 1.50 g wet weight of c e l l $ . The c e l l s were then suspended i n 0.27M mannitol buffered with 1 0 mM Pie-HCl, a t pH 7.4 and made 0.1 mM with respect t o EDTA, hence MTE buffer, t o a f i n a l concentration of 400 mg wet weight per 1 0 ml buffer. R o t e a s e VI was added a t 2.5 vg/40 mg wet weight and allowed t o r e a c t f o r 7 minutes a t 0' .
At t h e end of t h i s incubation, t h e c e l l s were homogenized v i t h a glass-Teflon grinder and t h e volume doubled with MTE buffer. Centrifugation a t 700 xg f o r 1 0 minutes separated undisrupted c e l l s and nuclei from t h e mitochondria-containing supernatant. Mitochondria were p e l l e t e d by centrifugation of t h i a supernatant a t 10,000 xg f o r 1 0 minutes. Mitochondria prepared by t h i s method showed coupled r e s p i r a t i o n i n t h e presence o f succinate and ADP (5) . This mitochondria r i c h p e l l e t was t r e a t e d with 0.5 vg digitonin per mg mitochondrial protein f o r 20 minutes a t 0' . Detergent action was stopped by t h e addition of M T E b u f f e r equal t o t h e suspending volume and i n n e r membrane v e s i c l e s p e l l e t e d by centrifugation a t 10,000 xg f o r 1 5 minutes. This inner membrane r i c h p e l l e t was suspended i n 30 mM K PO b u f f e r pH 7.2 t o a concentration of 80 t o 150 r g protein per ml f o r us: n i t h e enzyme source (5.21).
ASSAY
Urinary ketoacid concentrations were determined a s t h e i r methyl derivat i v e s by gas chrom tography (7). Enzyme ac v i t y was assessed by l i q u i d li s c i n t i i p t i o n of ltC02 released from t h e 1-C labeled ketoacid prepared from t h e 1-C labeled precursor amino acid a s previously described (8). Incubat i o n a t 37O was f o r t h e indicated times i n t h e legends t o figures and tables.
HEAT INACTIVATION
Aliquots of i s o l a t e d mitochondrial inner membranes were placed i n a v a t e r bath a t t h e indicated temperature f o r t h e appropriate time. with i n t e rmittant shaking t o prevent superheating. The samples were then placed on i c e u n t i l assay. Cofactors were present o r absent a s indicated. A minimum of 100 ug of protein were w e d f o r a l i q w t s . Protein was determined by t h e method of Lowry using bovine serum albumin as a standard (14) . Data analyses were aided by computer programs. A l l reagents were of highest p u r i t y available and made up i n deionized water.
RESULTS
I n order t o evaluate t h e biochemical response o f MSUD p a t i e n t s t o o r a l loading with thiamine, urinary output of t h e a-ketoacids was monitored along with BCKAD a c t i v i t y i n i s o l a t e d white blood c e l l s . represents t h e e f f e c t of o r a l thiamine on peripheral leukocyte BCKAD. To normalize t h e enzyme data, a s i n g l e control individual was used who was maintained on Recommended Dietary Allowance doses of thiamine and a normal diet. Before thiamine administration, valine, leucine, and isoleucine decarboxylation was 4.7, 2.3, and 5.5% of control, respectively. After thiamine these values rose t o 25.7, 16.6 and 23.0% of t h e same control.
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weeks and urinary branched chain a-ketoacid excretion and peripheral'white blood c e l l BCKAD a c t i v i t y was assayed. Bath 24 h r urinary excretion and BCKAD a c t i v i t y on admission was t h e same as day 28 of t h e i n i t i a l study and remained a t t h i a l e v e l throughout t h e t h r e e week t e s t period. The p a t i e n t ' s monthly ketoacidosis of unknown cause disappeared and f o r s i x years t h e p a t i e n t has remained s t a b l e on t h e r e s t r i c t i v e diet.supplemented with thiamine a t 100 mg/day and has required no further hospitalizations f o r treatment of metabolic acidosis.
Since t h e a c t i v i t y of t h e dehydrogenase was r e f l e c t e d i n cultured skin f i b r o b l a s t s , t h i s t i s s u e was used t o investigate t h e mechanisms producing t h e observed c l i n i c a l responses t o high doses of thiamine.
I s o l a t e d inner mitochondrial membranes provided a p a r t i a l l y p u r i f i e d enzyme preparation which eliminated complicating variables i n branched chain a-ketoacid decarboxylat i o n auch a s membrane transport of substrates and cofactors and transaminat i o n of aminoacid precursors. Data of Johnson and Connelly with beef l i v e r mitochondria suggested t h a t t h e branched chain a-ketoacid dehydrogenase was localized on t h e outside of t h e inner membranes, facing t h e intramitochond r i a l space (11) . When t h e outer membrane was removed by digitonin, t r e a tment, properly oriented inner membranes were obtained (21) Table I . Ninety minutes of incubation was used t o lower C O release t o b a s a l level. Again, note t h a t t h e absence of thiamine pyropho$hate during t h i s prein$ybation was necessary t o a t t a i n b a s a l a c t i v i t y (5). When NAD+, CoASH and Mg were present during preincubation and assay. BCKAD from normal c e l l s was maintained a t 1 8 fold above b a s a l level. This was not seen f o r enzyme from t h e mutant c e l l s . 
When thiamine pyropbosphate'was added along with t h e o t h e r cofactors during t h e assay period, an additional 3 f o l d stimulation was observed with normal enzyme and a s i m i l a r e f f e c t was now seen with BCKAD from t h e mutant cella. I d e n t i c a l r e s u l t s were s e e n w i t h mutant

These findings indicated t h a t both mutants had a decreased apparent Vm f o r thiamine pyrophosphate and t h e two f o l d higher o v e r a l l a c t i v i t y expressed by t h e Canadian p a t i e n t (Mutant B) as compared t o t h e Georgian (Mutant A) might r e f l e c t t h e i r c l i n i c a l findings of a more benign expression f o r t h e Canadian p a t i e n t when compared t o t h e Georgian.
Heat inactivation can often distinguish a mutant enzyme from i t s normal counterpart. This was not t r u e i n our inner membrane preparations. When denaturation a t 50° with time was measured, i d e n t i c a l r a t e s of inactivation were observed i n t h e mutant and normal membrane preparations (Figure 4 ). Of i n t e r e s t , however, was t h e s t a b i l i z i n g e f f e c t of thiamine pyrophosphate on these r a t e s of inactivation. When thiamine pyrophosphate was included during t h e heating process, t h e inactivation r a t e was retarded i n a similar manner f o r normal and mutant. T for normal BCKAD went from 5minwithout thiamine pyrophosphate t o 10 min i% t h e presence of thiamine pyrophosphate and f o r mutant BCKAD t h e respective times were 6 and 12 min.
DISCUSSION
These d a t a explore t h e mechanism of vitamin response and expand an e a r l i e r report from Canada about a thiamine-responsive p a t i e n t with ffiUD who had decreased plasma branched chain amino acids i n response t o high o r a l doses of thiamine (22) . A response t o thiamine i n pharmacological doses was characterized by both lowering o f urinary branched chain u-ketoacids and an increase i n BCKAD a c t i v i t y i n i s o l a t e d white c e l l s . I n i t i a l l y . t h e p a t i e n t ' s condition was controlled by dietary r e s t r i c t i o n of t h e branched chain amino acids which maintained urinary ketoacid excretion a t approximatel y 200 mg/24 hour (days 0-7. figure 1 ) . After t h r e e weeks of added thiamine, t h e output of these ketoacids was f u r t h e r reduced and has remained a t these lowered l e v e l s f o r s i x years.
I n addition, t h e s p e c i f i c a c t i v i t y of h i s peripheral leukocytes' BCKAD increased a t l e a s t 5 f o l d during t h i a treatment period and suggested t h a t improved enzyme function was t h e d i r e c t e f f e c t of pharmacological doses o f thiamine.
It was found previously t h a t t h e specif i c a c t i v i t y of normal adult l i v e r BCKAD increaaed a f t e r t h r e e weeks of o r a l loading with thiamine (4). A c l i n i c a l hypothesis t o c o r r e l a t e these findings suggests t h a t g r e a t e r intake of thiamine produced higher i n t r ac e l l u l a r concentrations of thiamine pyrophosphate, which increased t h e biol o g i c a l h a l f d i f e o f mitochondrial branched chain a-ketoacid dehydrogenase. Acute e f f e c t s of high-dose vitamin administration and removal would not be expected by t h i s hypothetical mechanisim. This, i n f a c t , v a s seen i n t h e Georgia patient. Additionally. removal of high l e v e l s of thiamine from t h i s p a t i e n t ' s d i e t did not r e s u l t i n increased urinary ketoacid l e v e l s and decreased BCKAD a c t i v i t y i n white blood c e l l s t o pretreatment l e v e l s within t h r e e subsequent weeks of observation.
Direct biochemical data t o explain t h e inn e f f e c t of high thiamine was sought by analysis of normal and mutant BCKAD p a r t i a l l y p u r i f i e d but bound t o inner mitochondria1 membranes of cultured human s k i n fibroblasts:
Despite marked reduction i n o v e r a l l a c t i v i t y . BCKAD prepared i n t h i s way from USUD mutant c e l l s had several s i m i l a r physical c h a r a c t e r i s t i c s when compared t o enzyme prepared from c e l l s with normal BCKAD a c t i v i t y . Decarboxylation of t h e branched chain a-ketoacids by both normal and mutant enzymes was reduced t o b a s a l l e v e l by incubation f o r 90 minutes without exogenous cofactors. Addition of TPP during t h i s period prevented t h i s f a l l i n a c t i v i t y ( 5 ) . Addition of TPP t o both preparations a t b a s a l l e v e l s produced a t h r e e fold stimulation i n COD r e l e a s e i n t h e presence of NAD+, CoASH and Mg2+ suggesting s i m i l a r cofactor requirements. Inactivation o f both normal and mutant BCKAD occurred within 15 minutes a t 50°. l h i s r a t e was slowed and T doubled by including thiamine Wrophosphate during heating i n both t h e norgal and mutant preparations indicating t h a t thiamine pyrophosphate produced thermostability.
Finally, an apparent & value of 1.6 uM f o r thiamine pyrophosphate binding i n BCKAD was i d e n t i c a l f o r t h e enzyme from mutant and normal c e l l s indicating a similar a f f i n i t y f o r t h i s cofactor. Important differences were found f o r t h e BCKAD from these mutants a s compared t o t h e enzyme from control c e l l s . The maximal r a t e of C02 release a t s a t u r a t i n g concentrations of thiamine pyrophosphate (vm) was g r e a t l y reduced for t h e two mutant enzymes studied. Since binding f o r thiamine pyrophosphate was normal (&) we suggest t h a t the f i r s t protein i n t h e complex. decarboxylase, functions normally i n substrate and cofactor binding. Thus. decreased a c t i v i t y would have t o be due t o an abnormality i n association of t h e component proteins, an abnormal c a t a l y t i c s i t e i n one o f t h e other two components o r decreased number of functioning decarboxylase subunits. The concept of unstable protein-protein i n t e r a c t i o n i s supported by t h e f a c t t h a t the normal BCKAD could be reconstituted by t h e addition of NAD+, CoASH and Mg2+ without thiamine pyrophosphate while both mutant complexes were unresponsive t o t h i s treatment (Table 1 ) . Differences i n V between t h e mut a n t s were r e f l e c t e d i n t h e in * study where i t was repoFted t h a t t h e Canadian p a t i e n t required only 1 0 mg thiamine per day f o r an acute lowering of plasma branched chain aminoacids while i n t h i s study 100 mg thiaminelday was determined t o be necessary and required t h r e e weeks f o r maximal effect. It has a l s o been reported t h a t t h e Canadian p a t i e n t had 40% o f normal BCKAD a c t i v i t y with 0.1 mM isoleucine but approached normal with 5 mM substrate (22) . Enzyme a c t i v i t y from t h e Georgia p a t i e n t has never exceeded 25% of control. This suggests t h a t d i f f e r e n t mutations a r e responsible f o r these two MSUD phenotypes.
--
These r e s u l t s do not provide clear. simple answers t o t h e mechanism by which thiamine was able t o improve t h e phenotypic expression of USUD i n these two patients. They do suggest t h a t t h e mutation does not involve t h e transmembrane transport o f thiamine, i t s conversion t o thiamine pyrophosphate o r i t s binding t o t h e decarhoxylase protein. Several other possibili t i e s f o r t h e thiamine e f f c -t exist. We know t h a t thiamine pyrophosphate functions a s t h e acceptor molecule f o r t h e acyl moity (24) . This primary r o l e may be limited i n a mutant multienzyme complex. A secondary r o l e f o r thiamine pyrophosphate might be t o a i d i n t h e proper alignment o f component proteins. This r o l e was demonstrated f o r thiamine pyrophosphate with b a c t e r i a l pyruvate decarboxylase (10) . Since BCKAD from mutants A & B had a decreased a c t i v i t y (Vm) a t s a t u r a t i n g l e v e l s of thiamine wrophosphate t h e l a r g e r amounts of t h i s cofactor could be necessary f o r optimum component association. Thus. when thiamine pyrophosphate was present i n quantity s u f f i c i e n t for t o t a l binding, then proper association might r e s u l t and l e a d t o a more s t a b l e complex b e t t e r able t o catalyze t h i s reaction. This p o s t u l a t e is supported by t h e f a c t t h a t mutant enzyme was more l a b i l e a t 37O and thiamine pyrophosphate s t a b i l i z e d both normal and mutant BcKAD a t both 37O and 50' . A s t a b i l i z a t i o n e f f e c t o f B6 on mutant cystathionine 8-synthase has a l s o been proposed (12.13).
More d i r e c t answers concerning t h e s p e c i f i c mutant gene product may be obtained through immunologic studies. Currently, normal m m a l i a n BCKAD i s being purified and antibodies raised t o i t s component proteins. Inner mitochondrial membranes from m U D mutant fibroblasts w i l l then be studied by immuno-histochemical methods i n an attempt t o s p e c i f i c a l l y identify t h e abnormal protein and record more precisely t h e e f f e c t s of thiamine wrophosphate on t h e biological r a t e s o f p r o t e i n degradation. A v e r a g e -* S M for nwber of determination indicated i n puenthescs. Printed in U.S.A.
